The research and development outsourcing company raised $96.5m from its initial public offering with corporate backer Symyx Technologies exiting and ATMI retaining its shares.
US-based research technology company Intermolecular priced its initial public offering (IPO) at $10.00 per share on Friday, below the expected price range of $12 to $14. The IPO raised $96.5m, $52.8m going to Intermolecular and $36.9m to selling shareholders after discounts and commissions.
Investors in Intermolecular include life sciences company Symyx Technologies, which merged with software corporation Accelrys last year. Symyx invested a total of about $2.5m in Intermolecular’s $20m series D and $15m series E round, and sold…
